Page last updated: 2024-11-02

piracetam and Lewy Body Disease

piracetam has been researched along with Lewy Body Disease in 2 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Lewy Body Disease: A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ukai, K1
Fujishiro, H1
Watanabe, M1
Kosaka, K1
Ozaki, N1
Singh, S1
Schwankhaus, J1

Other Studies

2 other studies available for piracetam and Lewy Body Disease

ArticleYear
Similarity of symptoms between transient epileptic amnesia and Lewy body disease.
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2017, Volume: 17, Issue:2

    Topics: 3-Iodobenzylguanidine; Aged; Amnesia; Anticonvulsants; Cognition Disorders; Electroencephalography;

2017
Olfactory disturbance in Parkinson disease.
    Archives of neurology, 2009, Volume: 66, Issue:6

    Topics: Aged; Anticonvulsants; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Biomarkers; Brain;

2009